It uses the same technology catalyst that gives a 1000% plus increase in absorption used in the Tetracycline breakthrough use for diabetic foot ulceration.
How would their patent differ? In the method of delivery. There is a big difference between a transdermal patch and a transdermal ointment. Breaking it down even further there is a difference from one ointment to another. It is the delivery that sets this apart. They were able to patent an antibiotic ointment with the same active ingredient as many others. Why? Because of the way it is absorbed into the body, the delivery. This delivery system can be used with other active ingredients and because it is unique in the way it works with the body it can be considered proprietary.
Market Data 
Markets 
